AU2001273150A1 - Secreted and transmembrane polypeptides and nucleic acids encoding the same - Google Patents
Secreted and transmembrane polypeptides and nucleic acids encoding the sameInfo
- Publication number
- AU2001273150A1 AU2001273150A1 AU2001273150A AU2001273150A AU2001273150A1 AU 2001273150 A1 AU2001273150 A1 AU 2001273150A1 AU 2001273150 A AU2001273150 A AU 2001273150A AU 2001273150 A AU2001273150 A AU 2001273150A AU 2001273150 A1 AU2001273150 A1 AU 2001273150A1
- Authority
- AU
- Australia
- Prior art keywords
- secreted
- same
- nucleic acids
- acids encoding
- transmembrane polypeptides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
Applications Claiming Priority (52)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21955600P | 2000-07-20 | 2000-07-20 | |
US60/219,556 | 2000-07-20 | ||
US22058500P | 2000-07-25 | 2000-07-25 | |
US22060700P | 2000-07-25 | 2000-07-25 | |
US22066400P | 2000-07-25 | 2000-07-25 | |
US22063800P | 2000-07-25 | 2000-07-25 | |
US22066600P | 2000-07-25 | 2000-07-25 | |
US22060500P | 2000-07-25 | 2000-07-25 | |
US22062400P | 2000-07-25 | 2000-07-25 | |
US60/220,666 | 2000-07-25 | ||
US60/220,638 | 2000-07-25 | ||
US60/220,624 | 2000-07-25 | ||
US60/220,585 | 2000-07-25 | ||
US60/220,664 | 2000-07-25 | ||
US60/220,607 | 2000-07-25 | ||
US60/220,605 | 2000-07-25 | ||
US22089300P | 2000-07-26 | 2000-07-26 | |
US60/220,893 | 2000-07-26 | ||
PCT/US2000/020710 WO2001009327A2 (fr) | 1999-07-28 | 2000-07-28 | Procede de prevention de la deterioration ou de la mort des cellules de la retine et de traitement des troubles oculaires |
AU63910/00 | 2000-07-28 | ||
US22242500P | 2000-08-01 | 2000-08-01 | |
US60/222,425 | 2000-08-01 | ||
US22713300P | 2000-08-22 | 2000-08-22 | |
US60/227,133 | 2000-08-22 | ||
AU70793/00 | 2000-08-23 | ||
PCT/US2000/023522 WO2001016319A2 (fr) | 1999-08-31 | 2000-08-23 | Compositions et procedes pour le traitement de maladies d'ordre immunologique |
PCT/US2000/023328 WO2001016318A2 (fr) | 1999-09-01 | 2000-08-24 | Polypeptides secretes et transmembranaires et acides nucleiques codant pour ceux-ci |
AU75730/00 | 2000-08-24 | ||
US60/000,000 | 2000-09-15 | ||
AU34346/01 | 2000-11-10 | ||
PCT/US2000/030873 WO2001040465A2 (fr) | 1999-11-30 | 2000-11-10 | Compositions et procedes de traitement de maladies d'ordre immunologique |
US25364600P | 2000-11-28 | 2000-11-28 | |
US60/253,646 | 2000-11-28 | ||
AU20554/01 | 2000-12-01 | ||
PCT/US2000/032678 WO2001040466A2 (fr) | 1999-12-01 | 2000-12-01 | Polypeptides secretes et transmembranaires et acides nucleiques codant ces polypeptides |
PCT/US2000/034956 WO2001046420A2 (fr) | 1999-12-23 | 2000-12-20 | Polypeptides homologues de l'il-17 et leurs utilisations therapeutiques |
US09/747,259 US6569645B2 (en) | 1999-05-14 | 2000-12-20 | IL-17 homologous polypeptides and therapeutic uses thereof |
AU25909/01 | 2000-12-20 | ||
US09/747,259 | 2000-12-20 | ||
PCT/US2001/006520 WO2001068848A2 (fr) | 2000-03-01 | 2001-02-28 | Polypeptides secretes et transmembranaires et acides nucleiques codant pour ces polypeptides |
AU2001268028 | 2001-02-28 | ||
AU2001255168 | 2001-03-01 | ||
PCT/US2001/006666 WO2001066740A2 (fr) | 2000-03-03 | 2001-03-01 | Compositions et methodes de traitement de maladies d'origine immune |
US09/816,744 | 2001-03-22 | ||
US09/816,744 US6579520B2 (en) | 1998-05-15 | 2001-03-22 | IL-17 related mammalian cytokine polypeptides (IL-17E) |
US09/854,208 US7217412B2 (en) | 1998-05-15 | 2001-05-10 | IL-17C related mammalian cytokine polypeptides |
US09/854,208 | 2001-05-10 | ||
US09/854,280 US7115398B2 (en) | 1998-05-15 | 2001-05-10 | IL-17 homologous polypeptides and therapeutic uses thereof |
US09/854,280 | 2001-05-10 | ||
AU2001265019 | 2001-05-25 | ||
PCT/US2001/017092 WO2001092331A2 (fr) | 2000-05-30 | 2001-05-25 | Compositions et methodes de traitement de maladies d'origine immune |
PCT/US2001/021066 WO2002008288A2 (fr) | 2000-07-20 | 2001-06-29 | Polypeptides secretes et transmembranaires et acides nucleiques codant ces polypeptides |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001273150A1 true AU2001273150A1 (en) | 2002-02-05 |
Family
ID=56290161
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001273150A Abandoned AU2001273150A1 (en) | 2000-07-20 | 2001-06-29 | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
AU7315001A Pending AU7315001A (en) | 2000-07-20 | 2001-07-02 | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU7315001A Pending AU7315001A (en) | 2000-07-20 | 2001-07-02 | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1354040A2 (fr) |
JP (1) | JP2004514420A (fr) |
AU (2) | AU2001273150A1 (fr) |
CA (1) | CA2416456A1 (fr) |
WO (1) | WO2002008288A2 (fr) |
Families Citing this family (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1012179A2 (fr) | 1997-09-12 | 2000-06-28 | Apotech R&D S.A. | Recepteurs "trail" riches en cysteine |
US7771719B1 (en) | 2000-01-11 | 2010-08-10 | Genentech, Inc. | Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E |
US20020106728A1 (en) * | 2000-06-20 | 2002-08-08 | Genentech, Inc. | NS4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders |
US20030232056A1 (en) | 1999-09-10 | 2003-12-18 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of ovarian cancer |
DK1897944T3 (da) * | 1999-12-23 | 2011-10-24 | Genentech Inc | IL-17 homologe polypeptider og terapeutisk anvendelse deraf |
US20030096969A1 (en) | 2000-06-02 | 2003-05-22 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
AU6531101A (en) * | 2000-06-02 | 2001-12-17 | Genentech Inc | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
EP1666497A3 (fr) * | 2000-06-02 | 2006-06-21 | Genentech, Inc. | Polypeptide, acides nucléiques le codant, et leur utilisation pour le diagnostic du cancer |
US20030096339A1 (en) | 2000-06-26 | 2003-05-22 | Sprecher Cindy A. | Cytokine receptor zcytor17 |
US20030017572A1 (en) * | 2000-09-25 | 2003-01-23 | Rajasekhar Bandaru | 56294 and 56629, novel human metalloproteases and uses thereof |
US20050048483A1 (en) * | 2000-09-28 | 2005-03-03 | Su Eric Wen | Novel secreted proteins and their uses |
CA2427800A1 (fr) | 2000-11-03 | 2002-05-10 | The Regents Of The University Of California | Polypeptides de prokineticine, et methodes et compositions associees |
CA2431861A1 (fr) | 2000-12-08 | 2002-06-13 | Curagen Corporation | Procede de detection et de traitement de pathologies associees au syndrome de la sclerose tubereuse |
DE10106835A1 (de) * | 2001-02-14 | 2002-09-05 | Basf Lynx Bioscience Ag | Signaltransduktionsproteine 15B3, 15B3-1 und 15B3-2 und zugrundeliegende DNA-Sequenzen |
GB2378183A (en) * | 2001-04-25 | 2003-02-05 | Smithkline Beecham Corp | Assays of the interaction between AXOR8 or AXOR52 and BV-8 ligand |
US7157558B2 (en) | 2001-06-01 | 2007-01-02 | Genentech, Inc. | Polypeptide encoded by a polynucleotide overexpresses in tumors |
CA2446610A1 (fr) * | 2001-06-06 | 2002-12-12 | Human Genome Sciences, Inc. | 20 proteines humaines secretees |
EP1961811B1 (fr) | 2002-01-18 | 2010-08-25 | ZymoGenetics, Inc. | Ligand de cytokine pour le traitement de l'asthme et de l'hyper-réactivité des voies respiratoires |
KR20040101502A (ko) * | 2002-04-16 | 2004-12-02 | 제넨테크, 인크. | 종양의 진단 및 치료 방법 및 이를 위한 조성물 |
US7141381B2 (en) | 2002-04-25 | 2006-11-28 | Bristol-Myers Squibb Company | Human leucine-rich repeat-containing proteins specifically expressed in the nervous system |
ES2318079T3 (es) | 2002-10-31 | 2009-05-01 | F. Hoffmann-La Roche Ag | Metodos para el diagnostico del cancer pancreatico y composicones uti les en los mismos. |
DE10254601A1 (de) * | 2002-11-22 | 2004-06-03 | Ganymed Pharmaceuticals Ag | Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung |
EP1573048A4 (fr) * | 2002-12-20 | 2007-02-14 | Avalon Pharmaceuticals | Proteine specifique du sein exprimee dans le cancer, et ses methodes d'utilisation |
EP1615659B1 (fr) | 2003-03-12 | 2014-04-16 | Genentech, Inc. | Utilisation de bv8 et/ou de eg-vegf pour promouvoir l'hématopoièse |
US7479479B2 (en) | 2003-04-30 | 2009-01-20 | Centocor, Inc. | CNGH0010 specific polynucleotides, polypeptides, antibodies, compositions, methods and uses |
EP1617802A4 (fr) * | 2003-04-30 | 2007-08-01 | Centocor Inc | Polynucleotides specifiques de cngh0010, polypeptides, anticorps, compositions, methodes et utilisations |
EP1503212B1 (fr) * | 2003-07-28 | 2007-05-23 | F. Hoffmann-La Roche Ag | Méthode de diagnostic de métastases, thérapie et composition utile à cela |
US20100031378A1 (en) | 2008-08-04 | 2010-02-04 | Edwards Joel A | Novel gene disruptions, compositions and methods relating thereto |
JPWO2005083075A1 (ja) * | 2004-03-02 | 2007-11-22 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 表皮分化に関与する新規遺伝子、およびその利用 |
PT1781682E (pt) | 2004-06-24 | 2013-05-14 | Mayo Foundation | B7-h5, um polipéptido coestimulante |
AU2005270078A1 (en) | 2004-07-02 | 2006-02-09 | Genentech, Inc. | Compositions and methods for treatment of non-hodgkin's lymphoma |
US7846438B2 (en) | 2004-08-03 | 2010-12-07 | Biogen Idec Ma Inc. | Methods of promoting neurite outgrowth with soluble TAJ polypeptides |
US8101183B2 (en) | 2005-05-06 | 2012-01-24 | Zymogentics, Inc. | Variable region sequences of IL-31 monoclonal antibodies |
US20130216542A1 (en) | 2005-05-06 | 2013-08-22 | Zymogenetics, Inc. | Variable region sequences of il-31 monoclonal antibodies and methods of use |
CN101198624B (zh) | 2005-05-06 | 2012-10-10 | 津莫吉尼蒂克斯公司 | Il-31单克隆抗体及使用方法 |
JP2007063225A (ja) | 2005-09-01 | 2007-03-15 | Takeda Chem Ind Ltd | イミダゾピリジン化合物 |
EP1991581A2 (fr) | 2006-01-10 | 2008-11-19 | Zymogenetics, Inc. | Procédés de traitement de la douleur et de l'inflammation dans les tissus neuronaux au moyen d'antagonistes de l'il-31 |
WO2007104034A2 (fr) | 2006-03-08 | 2007-09-13 | Takeda San Diego, Inc. | Activateurs de la glucokinase |
US8008332B2 (en) | 2006-05-31 | 2011-08-30 | Takeda San Diego, Inc. | Substituted indazoles as glucokinase activators |
WO2008079787A2 (fr) | 2006-12-20 | 2008-07-03 | Takeda San Diego, Inc. | Activateurs de glucokinase |
US8173645B2 (en) | 2007-03-21 | 2012-05-08 | Takeda San Diego, Inc. | Glucokinase activators |
EP2796466B1 (fr) | 2007-12-07 | 2017-11-22 | ZymoGenetics, Inc. | Molécules d'anticorps humanisés spécifiques pour l'IL-31 |
WO2009136286A2 (fr) | 2008-05-05 | 2009-11-12 | Novimmune Sa | Anticorps à réaction croisée anti-il-17a/il-17f et leurs procédés d'utilisation |
LT2398902T (lt) | 2009-02-20 | 2023-12-27 | Astellas Pharma Inc. | Vėžio diagnostikos ir gydymo būdai bei kompozicijos |
WO2010128407A2 (fr) | 2009-05-05 | 2010-11-11 | Novimmune S.A. | Anticorps anti-il-17f et leurs méthodes d'utilisation |
LT2499161T (lt) | 2009-11-11 | 2017-11-27 | Ganymed Pharmaceuticals Gmbh | Specifiniai antikūnai, skirti klaudinui 6 (cldn6) |
EP2404936A1 (fr) | 2010-07-06 | 2012-01-11 | Ganymed Pharmaceuticals AG | Thérapie du cancer utilisant des anticorps in vivo dirigés sur la cible CLDN6 |
LT3026064T (lt) | 2011-05-13 | 2019-01-25 | Ganymed Pharmaceuticals Gmbh | Antikūnai, skirti vėžio gydymui, ekspresuojantys klaudiną 6 |
US9848543B2 (en) | 2013-07-09 | 2017-12-26 | E I Du Pont De Nemours And Company | System and method for irrigation |
WO2015014376A1 (fr) | 2013-07-31 | 2015-02-05 | Biontech Ag | Diagnostic et thérapie du cancer impliquant des cellules souches cancéreuses |
GB201810301D0 (en) * | 2018-06-22 | 2018-08-08 | Evox Therapeutics Ltd | Combinatorial gene therapy |
CN111848792B (zh) * | 2020-07-16 | 2023-02-24 | 浙江省食品药品检验研究院 | 疫苗中牛血清白蛋白等杂质的抗体制备方法及检测方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5536637A (en) * | 1993-04-07 | 1996-07-16 | Genetics Institute, Inc. | Method of screening for cDNA encoding novel secreted mammalian proteins in yeast |
WO2000053756A2 (fr) * | 1999-03-08 | 2000-09-14 | Genentech, Inc. | Polypeptides secretes et transmembranaires et acides nucleiques codant ces polypeptides |
US6060249A (en) * | 1997-02-27 | 2000-05-09 | Genentech, Inc. | Method of selection for genes encoding secreted and transmembrane proteins |
AU3753499A (en) * | 1998-04-20 | 1999-11-08 | Paul B. Fisher | Colon cancer-associated antigens and their diagnostic and therapeutic uses |
JP2002538811A (ja) * | 1999-03-12 | 2002-11-19 | ヒューマン ジノーム サイエンシーズ, インコーポレイテッド | 49個のヒト分泌タンパク質 |
ATE449109T1 (de) * | 1999-06-15 | 2009-12-15 | Genentech Inc | Sekretierte und transmembran-polypeptide sowie nukleinsäuren zu deren kodierung |
WO2001059064A2 (fr) * | 2000-01-31 | 2001-08-16 | Human Genome Sciences, Inc. | Acides nucleiques, proteines et anticorps |
AU6531101A (en) * | 2000-06-02 | 2001-12-17 | Genentech Inc | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
-
2001
- 2001-06-29 CA CA002416456A patent/CA2416456A1/fr not_active Abandoned
- 2001-06-29 EP EP01952391A patent/EP1354040A2/fr not_active Withdrawn
- 2001-06-29 WO PCT/US2001/021066 patent/WO2002008288A2/fr active Search and Examination
- 2001-06-29 AU AU2001273150A patent/AU2001273150A1/en not_active Abandoned
- 2001-06-29 JP JP2002514192A patent/JP2004514420A/ja active Pending
- 2001-07-02 AU AU7315001A patent/AU7315001A/xx active Pending
Also Published As
Publication number | Publication date |
---|---|
AU7315001A (en) | 2002-01-30 |
CA2416456A1 (fr) | 2002-01-31 |
EP1354040A2 (fr) | 2003-10-22 |
WO2002008288A3 (fr) | 2003-08-14 |
JP2004514420A (ja) | 2004-05-20 |
WO2002008288A2 (fr) | 2002-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001268028A1 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
AU2001273150A1 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
AU2001265311A1 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
AU2002216610A1 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
AU7573000A (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
AU2055401A (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
AU2883700A (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
AU2883900A (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
IL139686A0 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
IL188579A0 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
WO1999046281A8 (fr) | Nouveaux polypeptides et acides nucleiques les codant | |
IL141535A0 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
AU2001249394A1 (en) | Secreted proteins and polynucleotides encoding them | |
AU2001239889A1 (en) | Polypeptides and nucleic acids encoding same | |
KR100514265B1 (en) | Secreted and Transmembrane polypeptides and Nucleic Acids Encoding the Same | |
AU1453601A (en) | Novel polypeptides and nucleic acids encoding same | |
AU2001234896A1 (en) | Novel polypeptides and nucleic acids encoding same | |
KR100532172B1 (en) | Secreted and Transmembrane polypeptides and Nucleic Acids Encoding the Same | |
AU5152700A (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
KR100528420B1 (en) | Secreted and Transmembrane polypeptides and Nucleic Acids Encoding the Same | |
KR100473124B1 (en) | Secreted and Transmembrane polypeptides and Nucleic Acids Encoding the Same | |
WO2002032961A8 (fr) | Nouveaux polypeptides et acides nucleiques les codant | |
AU2001234627A1 (en) | Novel polypeptides and nucleic acids encoding same | |
AU2001289282A1 (en) | Secreted proteins and polynucleotides encoding them | |
IL142673A0 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |